Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
44.47
2.61 (6.24%)
At close: Jun 13, 2025, 3:59 PM
44.48
0.02%
After-hours: Jun 13, 2025, 04:44 PM EDT
6.24% (1D)
| Bid | 35.5 |
| Market Cap | 2.65B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -150.05M |
| EPS (ttm) | -3.61 |
| PE Ratio (ttm) | -12.32 |
| Forward PE | -7.69 |
| Analyst | Buy |
| Ask | 45 |
| Volume | 1,067,286 |
| Avg. Volume (20D) | 702,200 |
| Open | 41.01 |
| Previous Close | 41.86 |
| Day's Range | 41.01 - 44.63 |
| 52-Week Range | 26.20 - 63.50 |
| Beta | 1.39 |
About APGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+6.14%
Apogee Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
-5.14%
Apogee Therapeutics shares are trading lower. The company reported Q3 financial results.
